| Identification | Back Directory | [Name]
Benzamide, 4-(4,5-dihydro-5,5-dimethyl-4-oxo-3-isoxazolyl)-N-(3-methyl-2-pyridinyl)-N-(3R)-3-piperidinyl- | [CAS]
2247649-76-7 | [Synonyms]
Benzamide, 4-(4,5-dihydro-5,5-dimethyl-4-oxo-3-isoxazolyl)-N-(3-methyl-2-pyridinyl)-N-(3R)-3-piperidinyl- | [Molecular Formula]
C23H26N4O3 | [MOL File]
2247649-76-7.mol | [Molecular Weight]
406.48 |
| Hazard Information | Back Directory | [Uses]
PCSK9-IN-31 (Compound WX002) is an orally active PCSK9 inhibitor. PCSK9-IN-31 can lower low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in high cholesterol fed model rats[1]. | [References]
[1] Wenjie Xu, et al. CRYSTAL FORM α OF COMPOUND A, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING CRYSTAL FORM. Patent. WO2020078170A1. |
|
|